地塞米松作为锁骨上臂丛阻滞神经周围佐剂优于右美托咪定:系统综述与间接荟萃分析
该系统综述与间接荟萃分析比较了地塞米松与右美托咪定作为锁骨上臂丛神经阻滞神经周围佐剂的效果。右美托咪定增加低血压和镇静风险。证据质量低。
要点
- 地塞米松较右美托咪定延长镇痛持续时间平均148分钟(95%CI 37-259分钟)。
- 两者对感觉/运动阻滞持续时间的影响相似,地塞米松不延长阻滞时间。
- 右美托咪定增加低血压(RR 6.3)和镇静(RR 15.8)风险。
核心结论
- 低质量证据表明两种佐剂均相似地延长感觉/运动阻滞,但地塞米松可能更优,显著延长镇痛持续时间且不增加低血压或镇静风险。
主要发现
- 地塞米松不延长感觉/运动阻滞持续时间。
- 总体偏倚风险为中等,存在发表偏倚,证据强度降级。
临床怎么用
- 对于锁骨上臂丛神经阻滞,地塞米松可作为优于右美托咪定的神经周围佐剂选择,以延长镇痛且减少低血压和镇静风险。
局限性
- 仅1项直接比较,主要依赖间接荟萃分析。
- 总体偏倚风险为中等,存在发表偏倚,证据质量低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Both dexamethasone and dexmedetomidine are effective peripheral nerve block (PNB) perineural adjuncts that prolong block duration. However, each is associated with side effects. With paucity of head-to-head comparisons of these adjuncts, the question of the best adjunct to mix with local anesthetics (LA) for PNB is unanswered. This meta-analysis aims to inform current practice and future research by identifying the superior adjunct by comparing dexamethasone and dexmedetomidine. METHODS: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, trials comparing the combination of perineural dexamethasone or dexmedetomidine with LA to LA alone for PNB were sought. The Cochrane Risk of Bias Tool was used to assess the methodological quality of trials, and indirect or network meta-analyses using random-effects modeling were planned. We designated duration of analgesia as a primary outcome. Secondary outcomes included sensory and motor block durations, sensory and motor block onset times, and the risks of hypotension, sedation, and neurological symptoms. RESULTS: Fifty trials were identified, including only 1 direct comparison, precluding a network meta-analysis. Indirect meta-analysis of 49 trials (3019 patients) was performed. Compared to dexmedetomidine, dexamethasone prolonged the duration of analgesia by a mean difference (95% confidence interval [CI]) of 148 minutes (37-259 minutes) (P = .003), without prolonging sensory/motor blockade. Dexmedetomidine increased rates of hypotension (risk ratio [95% CI], 6.3 [1.5-27.5]; P = .01) and sedation (risk ratio [95% CI], 15.8 [3.9-64.6]; P = .0001). Overall risk of bias was moderate, and publication bias was noted, resulting in downgrading evidence strength. CONCLUSIONS: There is low-quality evidence that both adjuncts similarly prolong sensory/motor blockade. However, dexamethasone may be a superior adjunct; it improves the duration of analgesia by a statistically significant increase, albeit clinically modest, equivalent to 2.5 hours more than dexmedetomidine, without the risks of hypotension or sedation. Future direct comparisons are encouraged.
引用
- Albrecht E, Vorobeichik L, Jacot-Guillarmod A, et al. Dexamethasone Is Superior to Dexmedetomidine as a Perineural Adjunct for Supraclavicular Brachial Plexus Block: Systematic Review and Indirect Meta-analysis. Anesth Analg. 2019. PMID: 30303864. doi:10.1213/ANE.0000000000003860
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。